terlipressin has been researched along with Ascites in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.23) | 18.2507 |
2000's | 8 (25.81) | 29.6817 |
2010's | 16 (51.61) | 24.3611 |
2020's | 6 (19.35) | 2.80 |
Authors | Studies |
---|---|
Aschenbach, R; Franken, P; Platzer, S; Ripoll, C; Schuhmacher, U; Stallmach, A; Steighardt, J; Teichgräber, U; Wienke, A; Zipprich, A | 1 |
Parikh, ND; Tapper, EB | 1 |
Beldi, G; Candinas, D; De Gottardi, A; Kohler, A; Perrodin, S | 1 |
Liu, CH; Wang, J; Xing, F | 1 |
An, Y; Bai, Z; Guo, X; Li, H; Méndez-Sánchez, N; Qi, X; Teschke, R | 1 |
Anand, A; Deep, A; Saxena, R | 1 |
Angus, PW; Chapman, B; Gow, PJ; Sinclair, M; Terbah, R; Testro, AG; Thwaites, PA | 1 |
Angeli, P; Piano, S; Tonon, M | 1 |
Baltayiannis, G; Christaki, M; Christodoulou, D; Christou, L; Kalambokis, GN; Koustousi, C; Tsiakas, I | 1 |
Bai, W; Cai, H; Chen, H; Fan, D; Guo, W; Han, G; Han, N; He, C; Li, K; Li, T; Li, X; Liu, L; Luo, B; Lv, Y; Niu, J; Wang, E; Wang, J; Wang, Q; Wang, Z; Wu, K; Xia, D; Xia, J; Xie, H; Yang, Z; Yao, L; Yin, Z; Yu, T; Yuan, J; Yuan, X; Zhang, H; Zhu, Y | 1 |
Hsu, SJ; Huang, HC | 1 |
Bendtsen, F; Egerod Israelsen, M; Gluud, LL; Krag, AA; Møller, S | 1 |
Egerod Israelsen, M; Gluud, LL; Krag, A | 1 |
Bertino, G; Crisafulli, E; Demma, S; Koukias, N; Privitera, G; Purrello, F; Spadaro, L; Tsochatzis, EA | 1 |
Angus, PW; Ardalan, ZS; Gow, PJ; Testro, AG; Vasudevan, A; Ye, B | 1 |
Appuswamy, E; Kaliamoorthy, I; Lakshmi, S; Malleeshwaran, S; Rajakumar, A; Reddy, MS; Rela, M; Varghese, J | 1 |
Kalambokis, GN; Tsianos, EV | 1 |
Bendtsen, F; Henriksen, JH; Krag, A; Mortensen, C; Møller, S | 1 |
Baltayiannis, G; Kalambokis, GN; Katsanou, A; Pappas, K; Tsianos, EV | 1 |
Biecker, E | 1 |
Cioffi, O; D'Adamo, G; Fimiani, B; Guardia, DD; Izzi, A; Pagano, A; Puoti, C; Tagliamonte, MR | 1 |
Davenport, A | 1 |
Bai, CX; He, BM; Huang, YY; Sun, JY; Wang, JY | 1 |
Singh Ranger, G | 1 |
De Santis, A; Giorgi, A; Laviano, A; Riggio, O; Rossi-Fanelli, F; Vaccaro, F | 1 |
Hayes, PC; Stanley, AJ; Therapondos, G | 1 |
Kumar, R; Nain, CK; Sharma, AK; Singh, B; Singh, V | 1 |
Calès, P; Dib, N; Oberti, F | 1 |
Bendtsen, F; Henriksen, JH; Holstein-Rathlou, NH; Krag, A; Larsen, FS; Møller, S | 1 |
Cailmail, S; Durand, F; Gadano, A; Hadengue, A; Lebrec, D; Moreau, R; Sogni, P; Soupison, T; Vachiery, F; Valla, D; Yang, S | 1 |
Arroyo, V | 1 |
10 review(s) available for terlipressin and Ascites
Article | Year |
---|---|
Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Topics: Adult; Ascites; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Muscle Cramp; Propranolol; Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Terlipressin; United States | 2023 |
[Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
Topics: Antihypertensive Agents; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2019 |
Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.
Topics: Arterial Pressure; Ascites; Clinical Trials as Topic; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Paracentesis; Postoperative Complications; Renal Circulation; Terlipressin; Treatment Outcome; Vascular Diseases; Vascular Resistance; Vasoconstrictor Agents | 2020 |
Management of ascites and hepatorenal syndrome.
Topics: Acute Kidney Injury; Albumins; Ascites; Bacterial Translocation; Diet, Sodium-Restricted; Diuretics; Hemodynamics; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Splanchnic Circulation; Terlipressin; Vasoconstrictor Agents; Vasodilation | 2018 |
Management of ascites in patients with liver cirrhosis: recent evidence and controversies.
Topics: Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Terlipressin | 2013 |
[Hepatorenal syndrome: diagnosis, treatment and prevention].
Topics: Albumins; Ascites; Drug Therapy, Combination; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Kidney; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin; Vasoconstrictor Agents | 2013 |
Acute kidney injury and hepatorenal syndrome in cirrhosis.
Topics: Acute Kidney Injury; Albumins; Ascites; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Transplantation; Lypressin; Portasystemic Shunt, Transjugular Intrahepatic; Terlipressin | 2015 |
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Topics: Acute Kidney Injury; Adrenal Insufficiency; Ascites; Creatinine; Evidence-Based Medicine; Hepatorenal Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Lypressin; Midodrine; Norepinephrine; Octreotide; Plasma Substitutes; Portasystemic Shunt, Transjugular Intrahepatic; Serum Albumin; Terlipressin; Vasodilator Agents; Vasopressins | 2016 |
Current management of the complications of portal hypertension: variceal bleeding and ascites.
Topics: Algorithms; Anti-Bacterial Agents; Ascites; Collateral Circulation; Diuretics; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Hormones; Hypertension, Portal; Liver Cirrhosis; Lypressin; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Secondary Prevention; Somatostatin; Spironolactone; Terlipressin; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2006 |
[Physiopathology of refractory ascites and the hepatorenal syndrome].
Topics: Ascites; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hypotension; Kidney; Liver Cirrhosis; Lypressin; Ornipressin; Paracentesis; Peritoneovenous Shunt; Peritonitis; Plasma Substitutes; Renin-Angiotensin System; Splanchnic Circulation; Sympathetic Nervous System; Tachycardia; Terlipressin; Vasoconstriction | 2002 |
10 trial(s) available for terlipressin and Ascites
Article | Year |
---|---|
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Topics: Acute Kidney Injury; Albumins; Ascites; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Prospective Studies; Quality of Life; Terlipressin | 2023 |
Effectiveness of terlipressin for prevention of complications after major liver resection - A randomized placebo-controlled trial.
Topics: Ascites; Female; Hepatorenal Syndrome; Humans; Male; Middle Aged; Terlipressin; Vasoconstrictor Agents | 2020 |
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Topics: Adult; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Ligation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Octreotide; Portasystemic Shunt, Transjugular Intrahepatic; Recurrence; Somatostatin; Stents; Survival Rate; Terlipressin; Time Factors; Treatment Outcome; Vasoconstrictor Agents | 2019 |
Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.
Topics: Acute Kidney Injury; Adult; Ascites; Bradycardia; Double-Blind Method; Female; Humans; Incidence; Infusions, Intravenous; Kidney Failure, Chronic; Length of Stay; Liver Function Tests; Liver Transplantation; Living Donors; Lypressin; Male; Middle Aged; Perioperative Period; Portal Pressure; Postoperative Complications; Severity of Illness Index; Terlipressin; Vasoconstrictor Agents | 2017 |
Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis.
Topics: Aged; Ascites; Blood Pressure; Cardiac Output; Electrocardiography; Female; Heart Function Tests; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Stroke Volume; Terlipressin; Tomography, Emission-Computed, Single-Photon; Vasoconstrictor Agents; Ventricular Function, Left | 2010 |
Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia.
Topics: Ascites; Diuresis; Drinking; Female; Humans; Hyponatremia; Liver Cirrhosis; Lypressin; Male; Middle Aged; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2010 |
The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
Topics: Adult; Aged; Albumins; Ascites; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatorenal Syndrome; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2011 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypressin; Male; Middle Aged; Paracentesis; Plasma Substitutes; Renin; Terlipressin; Vasoconstrictor Agents | 2006 |
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.
Topics: Ascites; Double-Blind Method; Female; Glomerular Filtration Rate; Hepatorenal Syndrome; Humans; Kidney; Kidney Diseases; Liver Cirrhosis, Alcoholic; Lypressin; Male; Middle Aged; Receptors, Vasopressin; Recovery of Function; Terlipressin; Vasoconstrictor Agents | 2007 |
Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
Topics: Adult; Antihypertensive Agents; Ascites; Atrial Natriuretic Factor; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis, Alcoholic; Lypressin; Male; Natriuresis; p-Aminohippuric Acid; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Terlipressin | 1997 |
11 other study(ies) available for terlipressin and Ascites
Article | Year |
---|---|
Use of terlipressin in critically ill children with liver disease.
Topics: Acute Kidney Injury; Adolescent; Ascites; Child; Creatinine; Critical Illness; Cyanosis; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Intensive Care Units, Pediatric; Ischemia; Liver Diseases; Male; Terlipressin; Vasoconstrictor Agents | 2020 |
Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis.
Topics: Ascites; End Stage Liver Disease; Hepatorenal Syndrome; Humans; Hydrothorax; Liver Cirrhosis; Lypressin; Outpatients; Severity of Illness Index; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis.
Topics: Aged; Area Under Curve; Arterial Pressure; Ascites; Cardiac Output; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Linear Models; Liver Cirrhosis; Logistic Models; Lypressin; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Retrospective Studies; Risk Factors; ROC Curve; Terlipressin; Time Factors; Vascular Resistance; Vasoconstrictor Agents | 2018 |
Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites.
Topics: Ambulatory Care; Ascites; Catheterization, Peripheral; Humans; Infusions, Intravenous; Lypressin; Male; Middle Aged; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2016 |
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome.
Topics: Adrenergic alpha-Agonists; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Midodrine; Terlipressin; Vasoconstrictor Agents | 2008 |
Diagnosis and therapy of ascites in liver cirrhosis.
Topics: Albumins; Ascites; Ascitic Fluid; Bacterial Infections; Clinical Trials as Topic; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Lypressin; Paracentesis; Peritonitis; Portasystemic Shunt, Transjugular Intrahepatic; Renin-Angiotensin System; Terlipressin | 2011 |
AKI in a patient with cirrhosis and ascites.
Topics: Acute Kidney Injury; Adult; Ascites; Creatinine; Female; Fluid Therapy; Glomerular Filtration Rate; Humans; Hypotension; Hypovolemia; Liver Cirrhosis; Lypressin; Oliguria; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2012 |
Terlipressin resolves ascites of cirrhotic rats through downregulation of aquaporin 2.
Topics: Alanine Transaminase; Animals; Aquaporin 1; Aquaporin 2; Arginine Vasopressin; Ascites; Bilirubin; Blood Pressure; Blood Urea Nitrogen; Down-Regulation; Kidney; Liver Cirrhosis; Lypressin; Male; Rats; Rats, Sprague-Dawley; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2012 |
Terlipressin and arterial blood volume after paracentesis for tense ascites in cirrhosis.
Topics: Ascites; Humans; Hypovolemia; Liver Cirrhosis; Lypressin; Paracentesis; Terlipressin; Vasoconstrictor Agents | 2002 |
Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.
Topics: Aged; Ascites; Bacterial Infections; Dose-Response Relationship, Drug; Fatal Outcome; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Infusions, Intravenous; Ischemia; Liver Cirrhosis; Lypressin; Male; Peritonitis; Rectum; Serum Albumin; Terlipressin; Vasoconstrictor Agents | 2003 |
Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study.
Topics: Adult; Ascites; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Lypressin; Male; Middle Aged; Pilot Projects; Portal System; Statistics, Nonparametric; Terlipressin | 2004 |